A New Functional Threshold for Minimally Invasive Lobectomy.


Journal

Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354

Informations de publication

Date de publication:
10 May 2024
Historique:
medline: 10 5 2024
pubmed: 10 5 2024
entrez: 10 5 2024
Statut: aheadofprint

Résumé

To assess the performance of a lower predicted postoperative (ppo) forced expiratory volume in 1 second (FEV1) or diffusion capacity of the lung for carbon monoxide (DLCO) (ppoFEV1/ppoDLCO) threshold to predict cardiopulmonary complications after minimally invasive surgery (MIS) lobectomy. Although MIS is associated with better postoperative outcomes than open surgery, MIS uses risk-assessment algorithms developed for open surgery. Moreover, several different definitions of cardiopulmonary complications are used for assessment. All patients who underwent MIS lobectomy for clinical stage I-II lung cancer from 2018 to 2022 at our institution were considered. The performance of a ppoFEV1/ppoDLCO threshold of <45% was compared against that of the current guideline threshold of <60%. Three different definitions of cardiopulmonary complications were compared: Society of Thoracic Surgeons (STS), European Society of Thoracic Surgeons (ESTS), and Berry et al. In 946 patients, the ppoFEV1/ppoDLCO threshold of <45% was associated with a higher proportion correctly classified (79% [95% CI, 76%-81%] vs. 65% [95% CI, 62%-68%]; P<0.001). The complication with the biggest difference in incidence between ppoFEV1/ppoDLCO of 45%-60% and >60% was prolonged air leak (33 [13%] vs. 34 [6%]; P<0.001). The predicted probability curves for cardiopulmonary complications were higher for the STS definition than for the ESTS or Berry definitions across ppoFEV1 and ppoDLCO values. The ppoFEV1/ppoDLCO threshold of <45% more accurately classified patients for cardiopulmonary complications after MIS lobectomy, emphasizing the need for updated risk-assessment guidelines for MIS lobectomy to optimize additional cardiopulmonary function evaluation.

Sections du résumé

OBJECTIVE OBJECTIVE
To assess the performance of a lower predicted postoperative (ppo) forced expiratory volume in 1 second (FEV1) or diffusion capacity of the lung for carbon monoxide (DLCO) (ppoFEV1/ppoDLCO) threshold to predict cardiopulmonary complications after minimally invasive surgery (MIS) lobectomy.
SUMMARY BACKGROUND DATA BACKGROUND
Although MIS is associated with better postoperative outcomes than open surgery, MIS uses risk-assessment algorithms developed for open surgery. Moreover, several different definitions of cardiopulmonary complications are used for assessment.
METHODS METHODS
All patients who underwent MIS lobectomy for clinical stage I-II lung cancer from 2018 to 2022 at our institution were considered. The performance of a ppoFEV1/ppoDLCO threshold of <45% was compared against that of the current guideline threshold of <60%. Three different definitions of cardiopulmonary complications were compared: Society of Thoracic Surgeons (STS), European Society of Thoracic Surgeons (ESTS), and Berry et al.
RESULTS RESULTS
In 946 patients, the ppoFEV1/ppoDLCO threshold of <45% was associated with a higher proportion correctly classified (79% [95% CI, 76%-81%] vs. 65% [95% CI, 62%-68%]; P<0.001). The complication with the biggest difference in incidence between ppoFEV1/ppoDLCO of 45%-60% and >60% was prolonged air leak (33 [13%] vs. 34 [6%]; P<0.001). The predicted probability curves for cardiopulmonary complications were higher for the STS definition than for the ESTS or Berry definitions across ppoFEV1 and ppoDLCO values.
CONCLUSIONS CONCLUSIONS
The ppoFEV1/ppoDLCO threshold of <45% more accurately classified patients for cardiopulmonary complications after MIS lobectomy, emphasizing the need for updated risk-assessment guidelines for MIS lobectomy to optimize additional cardiopulmonary function evaluation.

Identifiants

pubmed: 38726663
doi: 10.1097/SLA.0000000000006343
pii: 00000658-990000000-00884
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest.

Auteurs

Stijn Vanstraelen (S)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Kay See Tan (KS)

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.

Joe Dycoco (J)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Prasad S Adusumilli (PS)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Manjit S Bains (MS)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Matthew J Bott (MJ)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Robert J Downey (RJ)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Katherine D Gray (KD)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

James Huang (J)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

James M Isbell (JM)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Daniela Molena (D)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Bernard J Park (BJ)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Valerie W Rusch (VW)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Smita Sihag (S)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

David R Jones (DR)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Fiona and Stanley Druckenmiller Center for Lung Cancer Research, New York, NY, USA.

Gaetano Rocco (G)

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Fiona and Stanley Druckenmiller Center for Lung Cancer Research, New York, NY, USA.

Classifications MeSH